| Neonatal abstinence syndrome after methadone or buprenorphine exposure HE Jones, K Kaltenbach, SH Heil, SM Stine, MG Coyle, AM Arria, ... New England Journal of Medicine 363 (24), 2320-2331, 2010 | 1067 | 2010 |
| Hypertension Canada’s 2018 guidelines for diagnosis, risk assessment, prevention, and treatment of hypertension in adults and children KA Nerenberg, KB Zarnke, AA Leung, K Dasgupta, S Butalia, K McBrien, ... Canadian Journal of Cardiology 34 (5), 506-525, 2018 | 708 | 2018 |
| Hypertension Canada's 2016 Canadian hypertension education program guidelines for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of … AA Leung, K Nerenberg, SS Daskalopoulou, K McBrien, KB Zarnke, ... Canadian Journal of Cardiology 32 (5), 569-588, 2016 | 542 | 2016 |
| The 2015 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension SS Daskalopoulou, DM Rabi, KB Zarnke, K Dasgupta, K Nerenberg, ... Canadian Journal of Cardiology 31 (5), 549-568, 2015 | 491 | 2015 |
| Hypertension Canada’s 2020 comprehensive guidelines for the prevention, diagnosis, risk assessment, and treatment of hypertension in adults and children DM Rabi, KA McBrien, R Sapir-Pichhadze, M Nakhla, SB Ahmed, ... Canadian Journal of Cardiology 36 (5), 596-624, 2020 | 489 | 2020 |
| A critical appraisal of the human tumor stem-cell assay P Selby, RN Buick, I Tannock New England Journal of Medicine 308 (3), 129-134, 1983 | 471 | 1983 |
| Estimating the number of quit attempts it takes to quit smoking successfully in a longitudinal cohort of smokers M Chaiton, L Diemert, JE Cohen, SJ Bondy, P Selby, A Philipneri, ... BMJ open 6 (6), e011045, 2016 | 445 | 2016 |
| Hypertension Canada's 2017 guidelines for diagnosis, risk assessment, prevention, and treatment of hypertension in adults AA Leung, SS Daskalopoulou, K Dasgupta, K McBrien, S Butalia, ... Canadian Journal of Cardiology 33 (5), 557-576, 2017 | 424 | 2017 |
| Management of opioid use disorders: a national clinical practice guideline J Bruneau, K Ahamad, MÈ Goyer, G Poulin, P Selby, B Fischer, TC Wild, ... Cmaj 190 (9), E247-E257, 2018 | 420 | 2018 |
| Methods for quantification of exposure to cigarette smoking and environmental tobacco smoke: focus on developmental toxicology A Florescu, R Ferrence, T Einarson, P Selby, O Soldin, G Koren Therapeutic drug monitoring 31 (1), 14-30, 2009 | 413 | 2009 |
| The 2014 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension K Dasgupta, RR Quinn, KB Zarnke, DM Rabi, P Ravani, ... Canadian Journal of Cardiology 30 (5), 485-501, 2014 | 377 | 2014 |
| Unintended pregnancy in opioid-abusing women SH Heil, HE Jones, A Arria, K Kaltenbach, M Coyle, G Fischer, S Stine, ... Journal of substance abuse treatment 40 (2), 199-202, 2011 | 323 | 2011 |
| Abrupt discontinuation of psychotropic drugs during pregnancy: fear of teratogenic risk and impact of counselling. A Einarson, P Selby, G Koren Journal of Psychiatry and Neuroscience 26 (1), 44, 2001 | 321 | 2001 |
| Usage and longitudinal effectiveness of a Web-based self-help cognitive behavioral therapy program for panic disorder P Farvolden, E Denisoff, P Selby, RM Bagby, L Rudy Journal of medical Internet research 7 (1), e129, 2005 | 304 | 2005 |
| Treatment of opioid-dependent pregnant women: clinical and research issues HE Jones, PR Martin, SH Heil, K Kaltenbach, P Selby, MG Coyle, ... Journal of substance abuse treatment 35 (3), 245-259, 2008 | 228 | 2008 |
| The evolution of collaborative mental health care in Canada: A shared vision for the future N Kates, G Mazowita, F Lemire, A Jayabarathan, R Bland, P Selby, ... Canadian Journal of Psychiatry 56 (5), I1, 2011 | 206 | 2011 |
| Buprenorphine treatment of opioid‐dependent pregnant women: a comprehensive review HE Jones, SH Heil, A Baewert, AM Arria, K Kaltenbach, PR Martin, ... Addiction 107, 5-27, 2012 | 205 | 2012 |
| Higher binding of the dopamine D3 receptor-preferring ligand [11C]-(+)-propyl-hexahydro-naphtho-oxazin in methamphetamine polydrug users: a positron emission tomography study I Boileau, D Payer, S Houle, A Behzadi, PM Rusjan, J Tong, D Wilkins, ... Journal of Neuroscience 32 (4), 1353-1359, 2012 | 176 | 2012 |
| Article commentary: Covid-19 and persons with substance use disorders: Inequities and mitigation strategies OC Melamed, TS Hauck, L Buckley, P Selby, BH Mulsant Substance abuse 41 (3), 286-291, 2020 | 143 | 2020 |
| Therapeutic adventures outdoors: a demonstration of benefits for people with mental illness. MP Kelley, RD Coursey, PM Selby Psychiatric Rehabilitation Journal 20 (4), 1997 | 126 | 1997 |
